Results 11 to 20 of about 150,811 (312)

A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis

The Lancet Oncology, 2023
Summary Background Retroperitoneal sarcomas are tumours with a poor prognosis. Upfront characterisation of the tumour is difficult, and under-grading is common.
Amani Arthur, Matthew Orton, Robby Emsley, Sharon Vit, C. Kelly-Morland, Dirk C. Strauss, Jason Lunn, S. Doran, Hafida Lmalem, Axelle Nzokirantevye, S. Litière, S. Bonvalot, R. Haas, A. Gronchi, D. Van Gestel, A. Ducassou, Chandrajit P. Raut, P. Méeus, M. Spałek, M. Hatton, C. Le Péchoux, K. Thway, Cyril Fisher, R. Jones, P. Huang, C. Messiou   +25 more
semanticscholar   +1 more source

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

Annals of Surgical Oncology, 2021
Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of mesenchymal origin that include several well-defined histologic subtypes.
C. Swallow, D. Strauss, S. Bonvalot, P. Rutkowski, A. Desai, R. Gladdy, R. Gonzalez, D. Gyorki, M. Fairweather, W. V. van Houdt, E. Stoeckle, J. Park, M. Albertsmeier, C. Nessim, K. Cardona, M. Fiore, A. Hayes, D. Tzanis, J. Skoczylas, S. Ford, D. Ng, J. Mullinax, H. Snow, R. Haas, D. Callegaro, Myles J. Smith, T. Bouhadiba, S. Stacchiotti, Robin L. Jones, T. Delaney, C. Roland, C. Raut, A. Gronchi   +32 more
semanticscholar   +1 more source

Characteristics and outcomes of patients with primary abdominopelvic aggressive angiomyxoma: a retrospective review of 12 consecutive cases from a sarcoma referral center

BMC Surgery, 2023
Background Aggressive angiomyxoma (AAM) is a rare mesenchymal tumor that mostly arises from the pelvic and perineal soft tissues. Few studies reported its characteristics and outcomes previously due to its rarity and challenges of treatments.
Wenjie Li, Jun Chen, Enlong Zhang, Weida Chen, Yuru Hu, Chengli Miao, Chenghua Luo   +6 more
doaj   +1 more source

Retroperitoneal Sarcoma Care in 2021

Cancers, 2022
Simple Summary Soft-tissue sarcomas are exceedingly rare, accounting for
E. Schmitz, C. Nessim
semanticscholar   +1 more source

Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma

Current Oncology, 2022
Retroperitoneal tumors are extremely rare. More than 70% of primary retroperitoneal soft tissue tumors are malignant. The most common sarcomas in the retroperitoneum include liposarcomas and leiomyosarcoma, however other sarcomas, along with benign ...
Tanner Mack, B. Purgina
semanticscholar   +1 more source

Evaluation of outcomes in the management of primary sporadic desmoid-type fibromatosis at a specialist soft tissue sarcoma unit

European Journal of Medical Research, 2022
Background Desmoids are rare fibroblastic tumours whose treatment in any individual case presents a persistent challenge. We endeavoured to evaluate various clinicopathological factors contributing to tumour behaviour.
Misbah Khan, Max Almond, Samuel Ford, Anant Desai   +3 more
doaj   +1 more source

Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma

Current Oncology, 2023
Complete en bloc surgical resection offers the best opportunity for the cure of primary retroperitoneal sarcomas (RPS). The potential for disease recurrence, in the form of both loco-regional recurrence and distant metastases, underpins the rationale for
John Whitaker, Carolyn Nessim, Max Almond, Samuel J. Ford   +3 more
doaj   +1 more source

Solid Primary Retroperitoneal Masses in Adults: An Imaging Approach

Indian Journal of Radiology and Imaging, 2022
Mass lesions in the retroperitoneal space may be primary or secondary. Primary retroperitoneal mass lesions are relatively uncommon as compared to pathology that arises secondarily from retroperitoneal organs. These may be solid or cystic lesions.
V. Gulati, M. Swarup, J. Kumar
semanticscholar   +1 more source

Clinical outcome analysis of surgical treatment for primary retroperitoneal leiomyosarcoma

结直肠肛门外科, 2022
[Objective] To analyze the clinical outcomes of surgical treatment for primary retroperitoneal leiomyosarcoma (RLMS). [Methods] Clinical data of 41 RLMS patients treated at the Soft Tissue and Retroperitoneal Tumor Center of Peking University Cancer ...
Li Yang, Qiu Hui, Wu Jianhui, Li Chengpeng, Liu Bonan, Liu Qiao, Hao Chunyi, Lv Ang   +7 more
doaj   +1 more source

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.

The Lancet Oncology, 2020
BACKGROUND Unlike for extremity sarcomas, the efficacy of radiotherapy for retroperitoneal sarcoma is not established. The aim of this study was to evaluate the impact of preoperative radiotherapy plus surgery versus surgery alone on abdominal recurrence-
S. Bonvalot, A. Gronchi, C. Le Péchoux, C. Swallow, D. Strauss, P. Meeus, F. van Coevorden, S. Stoldt, E. Stoeckle, P. Rutkowski, M. Rastrelli, C. Raut, D. Hompes, A. De Paoli, C. Sangalli, C. Honoré, P. Chung, A. Miah, J. Blay, M. Fiore, J. Stelmes, A. D. Dei Tos, E. Baldini, S. Litière, S. Marréaud, H. Gelderblom, R. Haas   +26 more
semanticscholar   +1 more source